The pentose phosphate pathway and cancer

被引:1031
作者
Patra, Krushna C. [1 ]
Hay, Nissim [2 ,3 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA
[2] Univ Illinois, Coll Med, Dept Biochem & Mol Genet, Chicago, IL 60607 USA
[3] Jesse Brown VA Med Ctr, Res & Dev Sect, Chicago, IL 60612 USA
基金
美国国家卫生研究院;
关键词
6-PHOSPHOGLUCONATE DEHYDROGENASE; ADRIAMYCIN RESISTANCE; GLYCOLYTIC-ENZYMES; CELL-PROLIFERATION; GLUCOSE-METABOLISM; ENDOTHELIAL-CELLS; LEUKEMIA-CELLS; TUMOR-CELLS; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; TRANSKETOLASE;
D O I
10.1016/j.tibs.2014.06.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pentose phosphate pathway (PPP), which branches from glycolysis at the first committed step of glucose metabolism, is required for the synthesis of ribonucleotides and is a major source of NADPH. NADPH is required for and consumed during fatty acid synthesis and the scavenging of reactive oxygen species (ROS). Therefore, the PPP plays a pivotal role in helping glycolytic cancer cells to meet their anabolic demands and combat oxidative stress. Recently, several neoplastic lesions were shown to have evolved to facilitate the flux of glucose into the PPP. This review summarizes the fundamental functions of the PPP, its regulation in cancer cells, and its importance in cancer cell metabolism and survival.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 77 条
  • [1] Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses
    Anastasiou, Dimitrios
    Poulogiannis, George
    Asara, John M.
    Boxer, Matthew B.
    Jiang, Jian-kang
    Shen, Min
    Bellinger, Gary
    Sasaki, Atsuo T.
    Locasale, Jason W.
    Auld, Douglas S.
    Thomas, Craig J.
    Vander Heiden, Matthew G.
    Cantley, Lewis C.
    [J]. SCIENCE, 2011, 334 (6060) : 1278 - 1283
  • [2] Human glucose-6-phosphate dehydrogenase:: the crystal structure reveals a structural NADP+ molecule and provides insights into enzyme deficiency
    Au, SWN
    Gover, S
    Lam, VMS
    Adams, MJ
    [J]. STRUCTURE, 2000, 8 (03) : 293 - 303
  • [3] AYALA A, 1991, MOL CELL BIOCHEM, V105, P1
  • [4] NADPH CYTOCHROME-P-450 REDUCTASE ACTIVATION OF QUINONE ANTI-CANCER AGENTS TO FREE-RADICALS
    BACHUR, NR
    GORDON, SL
    GEE, MV
    KON, H
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1979, 76 (02) : 954 - 957
  • [5] TIGAR, a p53-inducible regulator of glycolysis and apoptosis
    Bensaad, Karim
    Tsuruta, Atsushi
    Selak, Mary A.
    Calvo Vidal, M. Nieves
    Nakano, Katsunori
    Bartrons, Ramon
    Gottlieb, Eyal
    Vousden, Karen H.
    [J]. CELL, 2006, 126 (01) : 107 - 120
  • [6] 6-PHOSPHOGLUCONOLACTONASE DEFICIENCY, A HEREDITARY ERYTHROCYTE ENZYME DEFICIENCY - POSSIBLE INTERACTION WITH GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY
    BEUTLER, E
    KUHL, W
    GELBART, T
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (11) : 3876 - 3878
  • [7] Inhibition of the oxidative and nonoxidative pentose phosphate pathways by somatostatin: a possible mechanism of antitumor action
    Boros, LG
    Brandes, JL
    Yusuf, FI
    Cascante, M
    Williams, RD
    Schirmer, WJ
    [J]. MEDICAL HYPOTHESES, 1998, 50 (06) : 501 - 506
  • [8] Boros LG, 1997, CANCER RES, V57, P4242
  • [9] Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?
    Boros, LG
    Lee, PWN
    Brandes, JL
    Cascante, M
    Muscarella, P
    Schirmer, WJ
    Melvin, WS
    Ellison, EC
    [J]. MEDICAL HYPOTHESES, 1998, 50 (01) : 55 - 59
  • [10] BRODIE AF, 1955, J BIOL CHEM, V212, P677